Nelson L. Michael spends much of his time researching Virology, Immunology, Antibody, Virus and Vaccination. His Virology study incorporates themes from Epitope, Antigen and Immune system. His studies deal with areas such as HIV vaccine, AIDS Vaccines and AIDSVAX as well as Immunology.
The concepts of his AIDSVAX study are interwoven with issues in Peptide sequence and Case-control study. The Virus study combines topics in areas such as Polymerase chain reaction and Genotype. His Vaccination research is multidisciplinary, relying on both Internal medicine, Clinical trial, Acquired immunodeficiency syndrome, Immunogenicity and RV 144.
His primary areas of study are Virology, Immunology, Antibody, Immune system and Virus. His study in Virology is interdisciplinary in nature, drawing from both Epitope and HIV vaccine. As part of one scientific family, Nelson L. Michael deals mainly with the area of Immunology, narrowing it down to issues related to the Acquired immunodeficiency syndrome, and often Internal medicine.
His research integrates issues of RNA, Peripheral blood mononuclear cell and Genotype in his study of Virus. His Viral load research incorporates themes from Viremia, CD8 and Viral replication. He has included themes like Placebo, Clinical trial and Immunogenicity in his Vaccination study.
Nelson L. Michael mainly investigates Virology, Immunology, Immune system, Antibody and Vaccination. In Virology, Nelson L. Michael works on issues like Epitope, which are connected to Antigen-presenting cell. His study in T cell, Viral load, Immunogenicity, Viral replication and Immunity falls within the category of Immunology.
Nelson L. Michael has included themes like Cytotoxic T cell, Viral rebound and Antigen in his Immune system study. Antibody and Phagocytosis are frequently intertwined in his study. His research integrates issues of HIV vaccine, Canarypox, Transcriptome and Zika virus in his study of Vaccination.
Nelson L. Michael mostly deals with Immunology, Immune system, Virology, Clinical trial and Vaccination. As part of his studies on Immunology, Nelson L. Michael often connects relevant subjects like Transcriptome. His studies examine the connections between Immune system and genetics, as well as such issues in Antibody, with regards to Lineage.
The Viremia research Nelson L. Michael does as part of his general Virology study is frequently linked to other disciplines of science, such as Extramural, therefore creating a link between diverse domains of science. His work investigates the relationship between Clinical trial and topics such as Adverse effect that intersect with problems in Randomized controlled trial. Nelson L. Michael works mostly in the field of Vaccination, limiting it down to concerns involving HIV vaccine and, occasionally, MF59, Cytotoxic T cell and Regimen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal.
The New England Journal of Medicine (2009)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
N. L. Michael;G. Chang;L. G. Louie;J. R. Mascola.
Nature Medicine (1997)
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
James B. Whitney;Alison L. Hill;Srisowmya Sanisetty;Pablo Penaloza-MacMaster.
GENETIC ACCELERATION OF AIDS PROGRESSION BY A PROMOTER VARIANT OF CCR5
Maureen P. Martin;Michael Dean;Michael W. Smith;Cheryl Winkler.
Vaccine protection against Zika virus from Brazil
Rafael A. Larocca;Peter Abbink;Jean Pierre S. Peron;Paolo M. de A. Zanotto.
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield.
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
Peter Abbink;Rafael A. Larocca;Rafael A. De La Barrera;Christine A. Bricault.
Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection
Victor Valcour;Thep Chalermchai;Napapon Sailasuta;Mary Marovich.
The Journal of Infectious Diseases (2012)
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland;Paul T. Edlefsen;Brendan B. Larsen;Sodsai Tovanabutra.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: